Clinical trial Recruiting at 1 site Observational Ages Any age to 100

Systemic Sclerosis Patient Cohort: Longitudinal Observation at Peking University Third Hospital

Official title: Clinical Cohort Study of Systemic Sclerosis

Run by Peking University Third Hospital · NCT07836361 · Data updated 2026-11-12

This observational study follows people with systemic sclerosis to understand how the disease progresses and to identify markers and potential targets for treatment.

Quick facts

Study typeObservational
AgesAny age to 100 Years
SexAll
Enrollment150 (estimated)
SponsorPeking University Third Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedJanuary 1, 2022
Main results expectedDecember 31, 2040
Study endsDecember 31, 2040
Registry record updatedSeptember 23, 2026
Trial IDNCT07836361 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults diagnosed with systemic sclerosis (1980 or 2013 criteria) who can provide informed consent and are likely to participate in follow-up.

Probably not a fit

Patients with extensive data gaps or lacking ability to participate in long-term follow-up may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational cohort study conducted at Peking University Third Hospital to collect clinical data from patients diagnosed with systemic sclerosis. The project aims to describe disease features, track progression over time, and explore biomarkers and possible drug targets using hospital resources and patient advocacy networks. Researchers will analyze collected information to improve understanding of pathogenesis, prognosis, and potential precision medicine approaches. Inclusion requires a confirmed systemic sclerosis diagnosis and informed consent; data completeness and ongoing follow-up are essential for eligibility.

Why it matters

Potential benefit: If successful, the study could improve understanding of systemic sclerosis, potentially guiding future interventions and biomarker-driven research.

How similar studies have gone: Similar international cohorts have contributed to understanding disease characteristics and helped identify biomarkers, though local data from China are still emerging.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who meet the 1980 or 2013 systemic sclerosis classification criteria
* Have signed informed consent.

Exclusion Criteria:

* More than 90% of data missing
* Patients without conditions for follow-up
* Patients who do not agree to participate in this study

Where it's running

  • Peking University Third Hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.